Screening was done by reviewing reference abstracts to exclude case reports, research in progress, conference abstracts, dissertations, books, and scientific meeting reports
Ch.2.2.2.2 (eds Picardo, M
In the CY 2017 OPPS/ASC final rule with comment period (81 FR 79719 and 79725), we created modifier PN to collect data for purposes of implementing section 603 but also to trigger payment under the newly adopted PFS-equivalent rates for nonexcepted items and services
To ensure patients were not given a GLP-1 agonist and discontinued use before therapeutic benefit, patients were filtered by those with documented GLP-1 agonist use at least twice and at least three months apart after diagnosis of MASLD/MASH
(2016) explored molecular mechanisms downstream of GLP-1R activation in the lateral septum
How tesamorelin intersects with lipid metabolism is discussed in our reference on how tesamorelin influences lipid metabolism through endocrine crosstalk